drugset / Trial / NCT06314685
Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 Years
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.
Timeline
- Start
- 2021-12-10
- Primary completion
- 2024-08-30
- Completion
- 2024-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine | Vaccine | — | — |
| Subject | Group ACYW135 Meningococcal Polysaccharide Vaccine | Vaccine | — | — |
| Subject | group A, C polysaccharide meningococcal and type b haemophilus Influenzal Conjugate vaccine | Vaccine | — | — |
Indications
No indication recorded.